http://www.xconomy.com/national/2009/09/09/targeted-genetics-survives-brush-with-death-sells-gene-therapy-ip-to-genzyme-for-7m/ Business + Technology in the Exponential Economy Sat, 11 Feb 2012 09:14:03 +0000 hourly 1 http://wordpress.org/?v=3.0.4 http://www.xconomy.com/national/2009/09/09/targeted-genetics-survives-brush-with-death-sells-gene-therapy-ip-to-genzyme-for-7m/comment-page-1/#comment-118725 BiotechExperts, Inc » Blog Archive » Gene Therapy News Fri, 02 Apr 2010 18:41:05 +0000 http://www.xconomy.com/?p=40741#comment-118725 [...] Therapeutics Inc (Introgen Therapeutics’ Houston unit gets new life), Targeted Genetics (Targeted Genetics Survives Brush With Death, Sells Gene Therapy IP to Genzyme for $7M), and Cell Genesys (BioSante, Cell Genesys merge in $38M deals). Most of the smaller, private [...] [...] Therapeutics Inc (Introgen Therapeutics’ Houston unit gets new life), Targeted Genetics (Targeted Genetics Survives Brush With Death, Sells Gene Therapy IP to Genzyme for $7M), and Cell Genesys (BioSante, Cell Genesys merge in $38M deals). Most of the smaller, private [...]

]]> http://www.xconomy.com/national/2009/09/09/targeted-genetics-survives-brush-with-death-sells-gene-therapy-ip-to-genzyme-for-7m/comment-page-1/#comment-118723 BiotechExperts » Blog Archive » Gene Therapy News Fri, 02 Apr 2010 18:32:05 +0000 http://www.xconomy.com/?p=40741#comment-118723 [...] Therapeutics Inc (Introgen Therapeutics’ Houston unit gets new life), Targeted Genetics (Targeted Genetics Survives Brush With Death, Sells Gene Therapy IP to Genzyme for $7M), and Cell Genesys (BioSante, Cell Genesys merge in $38M deals). Most of the smaller, private [...] [...] Therapeutics Inc (Introgen Therapeutics’ Houston unit gets new life), Targeted Genetics (Targeted Genetics Survives Brush With Death, Sells Gene Therapy IP to Genzyme for $7M), and Cell Genesys (BioSante, Cell Genesys merge in $38M deals). Most of the smaller, private [...]

]]>